Literature DB >> 18790975

Chronic lymphocytic leukaemia: a short overview.

E Montserrat1, C Moreno.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18790975     DOI： 10.1093/annonc/mdn460

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).

Authors:  V M Patel; K Balakrishnan; M Douglas; T Tibbitts; E Y Xu; J L Kutok; M Ayers; A Sarkar; R Guerrieri; W G Wierda; S O'Brien; N Jain; H M Stern; V Gandhi
Journal:  Leukemia       Date:  2016-12-26       Impact factor: 11.528

Review 2.  Ofatumumab.

Authors:  Mark Sanford; Paul L McCormack
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

3.  Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.

Authors:  Agnieszka W Kubica; Peter S Rose; Amy L Weaver; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

4.  OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway.

Authors:  Li-Yuan Bai; Yihui Ma; Samuel K Kulp; Shu-Huei Wang; Chang-Fang Chiu; Frank Frissora; Rajeswaran Mani; Xiaokui Mo; David Jarjoura; John C Byrd; Ching-Shih Chen; Natarajan Muthusamy
Journal:  Br J Haematol       Date:  2011-04-07       Impact factor: 6.998

Review 5.  Sequencing of chronic lymphocytic leukemia therapies.

Authors:  Jacqueline C Barrientos
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 6.  Management of Chronic Lymphocytic Leukemia in the Elderly.

Authors:  Jacqueline C Barrientos
Journal:  Cancer Control       Date:  2015-10       Impact factor: 3.302

7.  Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner.

Authors:  Avital F Barak; Hadas Lewinsky; Michal Perpinial; Victoria Huber; Lihi Radomir; Mattias P Kramer; Lital Sever; Yochai Wolf; Mika Shapiro; Yair Herishanu; Steffen Jung; Shirly Becker-Herman; Idit Shachar
Journal:  Oncogene       Date:  2019-11-26       Impact factor: 9.867

8.  VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.

Authors:  T Prezma; A Shteinfer; L Admoni; Z Raviv; I Sela; I Levi; V Shoshan-Barmatz
Journal:  Cell Death Dis       Date:  2013-09-19       Impact factor: 8.469

Review 9.  Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy.

Authors:  Sara Martinelli; Antonio Cuneo; Luca Formigaro; Maurizio Cavallari; Enrico Lista; Francesca Maria Quaglia; Maria Ciccone; Antonella Bardi; Eleonora Volta; Elisa Tammiso; Elena Saccenti; Olga Sofritti; Giulia Daghia; Massimo Negrini; Melissa Dabusti; Paolo Tomasi; Sabrina Moretti; Francesco Cavazzini; Gian Matteo Rigolin
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-15       Impact factor: 2.576

Review 10.  Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.

Authors:  Varda Shoshan-Barmatz; Yakov Krelin; Anna Shteinfer-Kuzmine; Tasleem Arif
Journal:  Front Oncol       Date:  2017-07-31       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.